Rachel Lane
InvestorPrincipal at Versant Ventures
San Francisco Bay Area
Writes $100K – $5M checks · typically $1.5M
Experience
- Xaira TherapeuticsSVP Business Development and Operationscurrent2026 — presentSSF
- Belharra TherapeuticsMember Board of Directorscurrent2025 — presentSan Francisco Bay Area / San Diego
- Belharra TherapeuticsChief Business Officer2023 — 2025San Francisco Bay Area
- Belharra TherapeuticsInterim Chief Business Officer2021 — 2023San Francisco Bay Area
- Nighthawk TherapeuticsInterim Chief Business Officer2021 — 2024
- Levator TherapeuticsBoard Member2023San Diego, California, United States
- Kate TherapeuticsBoard Observer2021 — 2023California, United States
- Inception TherapeuticsChief Business Officer2021 — 2023San Diego, California, United States
- Santa Ana Bio, IncBoard Observer2020 — 2023San Francisco Bay Area
- Versant VenturesPrincipal2020 — 2023San Francisco Bay Area
- CODA BiotherapeuticsBoard Observer2021 — 2022San Francisco Bay Area
- iECURE, inc.Board Observer2020 — 2022Philadelphia, Pennsylvania, United States
- Calico Life SciencesDirector, Business Development2019 — 2020San Francisco Bay Area
- Ovid TherapeuticsLead, Portfolio Strategy and New Product Commercialization2018 — 2019Greater New York City Area
- Ovid TherapeuticsSr Director, Business Development2018New York
- Ovid TherapeuticsDirector, Business Development2016 — 2018Greater New York City Area
- H.C. Wainwright & Co., LLCEquity Research, Biotechnology2014 — 2016Greater New York City Area
- Alzheimer's Drug Discovery FoundationAssociate Director, Scientific Affairs2012 — 2014New York, New York
- Alzheimer's Drug Discovery FoundationAssistant Director, Scientific Affairs2011 — 2012Greater New York City Area
- Ascent Biomedical VenturesConsultant2010 — 2012New York, New York
Education
- The University of SheffieldPh.D., Molecular and Cell Biology2004 — 2008
- Sheffield Hallam UniversityBSc (Hons), Biomedical Sciences2000 — 2004
Skills & more
Cell Biology27Alzheimer's disease4Venture Capital4Venture Philanthropy1Biochemistry22Drug Discovery27Clinical Development8Lifesciences7Molecular Biology20Tissue Culture4Genetics7
From Rachel's professional profile.
Colleagues at Versant Ventures
Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Venture Advisor at Intuitive Ventures
Bill Link
Investor at Versant Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures
Frequently asked questions
- Where does Rachel Lane work?
- Rachel Lane is Principal at Versant Ventures.
- What check size does Rachel Lane write?
- Rachel Lane typically writes checks of $100K – $5M.
Same school
Also attended The University of Sheffield73
Dominic JacquessonInvestor at Index VenturesFrancois PrinslooInvestor at MedicxiRoberto BonanzingaPartner at Inreach VenturesAndrew McLoughlinBrit in San Francisco; seed-stage venture capital investorXavier MesnierPartner, Head of Frontiers in Health & Bio Investments at Verve VenturesRyan ProcterHead of Marketing & Communications at Nauta Capital
+ 67 more
Also attended Sheffield Hallam University17
Claire BarkerExecutive Assistant at Five Elms CapitalVictoria GagoVenture Partner - Blockchain at Encomenda VCPete NewtonRegional Executive at UKSERoman ScharfFounder and Partner at 3VCKieran SherlockPartner & Property Director at ImbibaPaul TranterManaging Director & Senior Partner; Chief Financial Officer at The Boston Consulting Group
+ 11 more
Shared employers
Also worked at Xaira Therapeutics7
Konstantine BuhlerInvestor at Sequoia CapitalScott GottliebPartner at New Enterprise Associates (NEA)Dusan PerovicPartner at Two Sigma VenturesVikram BajajAdvisor at Foresite CapitalUplaksh KumarVenture Partner at Foresite CapitalGreg YapPartner at Menlo Ventures
+ 1 more






































